tbuckley/cabot-search huggingface dataset:
Endothelium-Targeted NF-κB siRNA Nanogel for Magnetic Resonance Imaging and Visualized-Anti-inflammation Treatment of Atherosclerosis
Authors: Yuanyuan Guo, Fujun Wang, Sunli Wan, Xinhua Liu, Yu Huang, Miao Xie, Xiaoer Wei, Wangshu Zhu, Tingting Yao, Yuehua Li, Chuan Zhang, Yueqi Zhu
Journal: Biomaterials (2024)
Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic naïve patients with psoriasis: A retrospective cohort study.
Authors: Ana Ormaza Vera, Chunghwan Ro, Waleed Adawi, Alexander Yap, Abby S Van Voorhees, Clinton W Enos
Journal: Journal of the American Academy of Dermatology (2024)
India’s evolving digital health strategy
Authors: Aditya Narayan, Indu Bhushan, Kevin Schulman
Journal: npj Digital Medicine (2024)

India's evolving digital health strategy leverages innovative technologies to enhance access to healthcare services. This paper explores the key components of India's digital health transformation, including the Ayushman Bharat Digital Mission (ABDM) and India's integration of biometric identification and digital infrastructure to improve healthcare delivery. The lessons learned from India's large-scale implementation of digital health provide valuable insights for global health markets and digital transformations in healthcare systems.
Altered B-cell, plasma cell and antibody immune profiles in blood of systemic mastocytosis
Authors: Alba Pérez-Pons, Ana Henriques, Teresa Contreras Sanfeliciano, María Jara-Acevedo, Paula Navarro-Navarro, Andrés C García-Montero, Iván Álvarez-Twose, Quentin Lecrevisse, Rafael Fluxa, Laura Sánchez-Muñoz, Carolina Caldas, Julio Pozo, Óscar González-López, Martín Pérez-Andrés, Andrea Mayado, Alberto Orfao
Journal: Journal of Allergy and Clinical Immunology (2024)
A partial loss-of-function variant in STAT6 protects against T2 asthma
Authors: Katla Kristjansdottir, Guðmundur L Norddahl, Erna V Ivarsdottir, Gisli H Halldorsson, Gudmundur Einarsson, Kristbjörg Bjarnadóttir, Gudrun Rutsdottir, Asgeir O Arnthorsson, Christian Erikstrup, Steinunn Gudmundsdottir, Kristbjorg Gunnarsdottir, María I Gunnbjornsdottir, Bjarni V Halldorsson, Hilma Holm, Dora Ludviksdottir, Bjorn R Ludviksson, Søren Brunak, Mie Topholm Bruun, Christina Mikkelsen, Susan Mikkelsen, Bitten Aagaard Jensen, Erik Sørensen, Simon Francis Thomsen, Henrik Ullum, Isleifur Olafsson, Pall T Onundarson, Sisse Rye Ostrowski, Saedis Saevarsdottir, Olof Sigurdardottir, Bardur Sigurgeirsson, Audunn S Snaebjarnarson, Gardar Sveinbjornsson, Gudny E Thorlacius, Gudmar Thorleifsson, Vinicius Tragante, Brynjar Vidarsson, Celeste Porsbjerg, Unnur S Bjornsdottir, Patrick Sulem, Daniel F Gudbjartsson, Pall Melsted, Ole Bv Pedersen, Ingileif Jonsdóttir, Thorunn A Olafsdottir, Kari Stefansson
Journal: Journal of Allergy and Clinical Immunology (2024)
A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease
Authors: Qingxia Huang, Sami F Qadri, Hua Bian, Xiaoxuan Yi, Chenhao Lin, Xinyu Yang, Xiaopeng Zhu, Huandong Lin, Hongmei Yan, Xinxia Chang, Xiaoyang Sun, Shuai Ma, Qi Wu, Hailuan Zeng, Xiqi Hu, Yan Zheng, Hannele Yki-Järvinen, Xin Gao, Huiru Tang, Mingfeng Xia
Journal: Journal of Hepatology (2024)
Comparing recurrence rates between endoscopic mucosal resection and endoscopic submucosal dissection in Barrett’s endoscopic therapy: timing and definitions matter!
Authors: Kornpong Vantanasiri, Prasad G. Iyer
Journal: Endoscopy (2024)

Endoscopic eradication therapy (EET) is the standard of care for treatment of Barrett's esophagus (BE)-related neoplasia. It consists of a combination of endoscopic resection with endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) followed by ablation [1]. Resection enables removal of all visible lesions that may reflect advanced neoplastic lesions. Ablation enables eradication of any remaining flat BE mucosa to achieve complete remission of intestinal metaplasia (CRIM). EMR was initially preferred given its efficiency and simplicity. ESD was later developed to enable en bloc resection regardless of lesion size, but it is technically more challenging and time consuming.
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Authors: Jan C Koch, Andreas Leha, Helen Bidner, Isabell Cordts, Johannes Dorst, René Günther, Daniel Zeller, Nathalie Braun, Moritz Metelmann, Philippe Corcia, Elisa De La Cruz, Patrick Weydt, Thomas Meyer, Julian Großkreutz, Marie-Hélène Soriani, Shahram Attarian, Jochen H Weishaupt, Ute Weyen, Josua Kuttler, Gabriela Zurek, Mary-Louise Rogers, Emily Feneberg, Marcus Deschauer, Christoph Neuwirth, Joanne Wuu, Albert C Ludolph, Jens Schmidt, Yvonne Remane, William Camu, Tim Friede, Michael Benatar, Markus Weber, Paul Lingor
Journal: The Lancet Neurology (2024)
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial
Authors: Tiffany J Braley, Dawn M Ehde, Kevin N Alschuler, Roderick Little, Yee To Ng, Yuqi Zhai, Gloria von Geldern, Ronald D Chervin, Deirdre Conroy, Thomas R Valentine, Andrew R Romeo, Nicholas LaRocca, Maysa Hamade, Allison Jordan, Mini Singh, Benjamin M Segal, Anna L Kratz
Journal: The Lancet Neurology (2024)
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
Authors: Keith W Muir, Gary A Ford, Ian Ford, Joanna M Wardlaw, Alex McConnachie, Nicola Greenlaw, Grant Mair, Nikola Sprigg, Christopher I Price, Mary Joan MacLeod, Sofia Dima, Marius Venter, Liqun Zhang, Eoin O'Brien, Ranjan Sanyal, John Reid, Laszlo K Sztriha, Syed Haider, William N Whiteley, James Kennedy, Richard Perry, Sekaran Lakshmanan, Annie Chakrabarti, Ahamad Hassan, Richard Marigold, Senthil Raghunathan, Don Sims, Mohit Bhandari, Ivan Wiggam, Khalid Rashed, Chris Douglass
Journal: The Lancet Neurology (2024)
Low-pressure self-expandable metal stent insertion for obstructive colon cancer using water and gel immersion
Authors: Takahiro Muramatsu, Masakatsu Fukuzawa, Midori Mizumachi, Satoshi Shimai, Miki Wada, Kazuki Yamamoto, Takao Itoi
Journal: Endoscopy (2024)

Self-expandable metal stents (SEMSs) are commonly used as a bridge-to-surgery or palliative treatment for obstructive colorectal cancer [1]. Although technical and clinical success rates are high, adverse events such as perforation, migration, and sepsis [2] [3] [4] may occur owing to the poor visual field due to stool and failure to identify the luminal opening of the tumor, air over-insufflation, and unreasonable guidewire manipulation. Gel immersion can be used to improve the endoscopic view [5]. Herein, we describe a SEMS insertion with a clear view and lower intraluminal pressure using water and gel immersion ([Video 1]).
Resection of a large esophageal schwannoma: operative transition from submucosal tunneling endoscopic resection to partial full-thickness resection
Authors: Yipeng Yuan, Jixin Zhang, Long Rong
Journal: Endoscopy (2024)

The vast majority of esophageal tumors are malignant esophageal cancers, with benign esophageal tumors accounting for a negligible fraction, approximately less than 1% according to previous limited autopsy studies [1]. Primary schwannoma in the digestive tract is rare, especially in the esophagus, which is easily misdiagnosed as leiomyoma.
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study
Authors: Ghulam Rehman Mohyuddin, Hira Mian, Anastasia Gayowsky, Hsien Seow, Rajshekhar Chakraborty, Gregory R. Pond, Samer Al Hadidi, Alissa Visram
Journal: Blood Cancer Journal (2024)
Application of Duty of Candour legislation in post-colonoscopy colorectal cancer: a prospective cohort study
Authors: Emma Saunsbury, Nicholas E. Burr, David Beaton, Kate McSweeney, Jo Mason-Higgins, Nigel Trudgill, Eva J. A. Morris, Roland Valori
Journal: Endoscopy (2024)

Abstract Background This study investigated the application of Duty of Candour (DoC) legislation in the context of post-colonoscopy colorectal cancers (PCCRCs). DoC mandates transparent disclosure of notifiable safety incidents to patients in the English National Health Service, including incidences leading to severe or moderate harm. This study aimed to analyze the application of DoC in PCCRCs, improve understanding of the legislation, and identify challenges in DoC implementation. Methods A national audit of PCCRCs was conducted between September 2021 and May 2022. PCCRCs were identified using linked administrative datasets, and root-cause analyses were performed using structured templates. “Avoidability” and harm were categorized into specific levels, and guidance was provided on improving consistency in judgments. Results 16% of 1724 PCCRCs resulted in major harm or death, of which 27% (75) were probably or definitely avoidable. Hospitals deemed DoC discharge necessary in only 53% of these cases. When including moderate harm, 11% of all PCCRCs would trigger DoC discharge, yet this was deemed necessary in only 45% of such cases. Conclusions There is inconsistent application of DoC in PCCRC cases. Challenges include determining “avoidability” and harm, particularly when diagnosis is delayed. Clearer guidance and definitions of harm are needed to improve adherence to regulations.
Efficacy of endoscopic submucosal tunnel dissection in the management of a large esophageal cavernous hemangioma
Authors: Guang Yang, Silin Huang, Suhuan Liao, Yang Lv, Wei Gong, Qiuping Qiu, Nan Liu
Journal: Endoscopy (2024)

A 44-year-old man presented with symptoms of gastroesophageal reflux disease and dysphagia. Gastroscopy revealed a 3-cm, half-circumferential, bluish-purple esophageal mass located in the mid-esophageal region ([Fig. 1] a). Computed tomography revealed a soft tissue nodule causing significant stenosis of the esophageal lumen. Endoscopic ultrasound confirmed a well-demarcated, moderately hyperechoic submucosal lesion, characteristic of an esophageal cavernous hemangioma ([Fig. 1] b). Subsequent to a detailed consultation, endoscopic submucosal tunnel dissection (ESTD) was undertaken ([Video 1]).
Acquired double pylorus secondary to a completely epithelialized gastroduodenal fistula
Authors: Cong Yuan, Fan Liu, Chun-Hui Xi, Ke Pu, Guodong Yang, Xian-Fei Wang, Xue-Mei Lin
Journal: Endoscopy (2024)

A 74-year-old man underwent a gastroscopic reevaluation due to a prior history of gastric antral ulcers two years ago ([Fig. 1] a). The carbon-13 urea breath test was negative. The patient had taken a non-steroidal anti-inflammatory drug (diclofenac sodium) and proton pump inhibitors (omeprazole) periodically for back pain and ceased the NSAID six months ago. Esophagogastroduodenoscopy showed two pyloric channels that were communicating the gastric antrum with the duodenal bulb ([Fig. 1] b, [Video 1]). The endoscope could be passed into the duodenum through either channel. The channel located on the side of the lesser curvature, although fully epithelialized, had failed to contract, suggesting an accessory pylorus ([Fig. 2] a, b). This patient was clinically asymptomatic but at risk for ulcer recurrence, and endoscopic follow-up was continued.
The strange cat scratch colon signs in a patient with multiple colon tumors
Authors: Li Xu, Haijun Cao, Shanshan Chen, Jinfeng Dai, Haochen Zhang, Zemin Feng, Xuan Huang
Journal: Endoscopy (2024)

A 63-year-old man underwent a colonoscopy due to abdominal distension, during which signs of cat scratch colon were found ([Fig. 1] a, b), accompanied by 10 colon tumors (3 in the cecum, 4 in the descending colon, and 3 in the sigmoid colon). Carbon dioxide was used for insufflation, and the patient did not feel discomfort during the colonoscopy. Initially, cat scratch colon was visible only in the cecum. During endoscopic mucosal resection (EMR) for colon tumors with submucosal injection (a mixture of methylene blue and physiological saline), this condition appeared again in the descending colon ([Fig. 1] c) but not in the sigmoid colon ([Fig. 1] d). Three months after EMR, the patient underwent a retest colonoscopy. Multiple white scars were visible in the cecum. After three minutes of observation, no signs of cat scratch colon were observed ([Fig. 1] e, f, [Video 1]).
Incidence of scabies from 1996 to 2022: A retrospective single centre cohort study from Finland
Authors: Ella Jokela, Anna Mikola, Eetu Kiviniemi, Jari Jokelainen, Suvi-Päivikki Sinikumpu, Laura Huilaja
Journal: British Journal of Dermatology (2024)

Our observation of increasing numbers of cases of scabies being diagnosed in our clinic in Oulu, northern Finland, led us to conduct a retrospective study of the epidemiology of scabies in our area from 1996 to 2022. We found a pattern of growing incidence during that period, especially among adolescents in more recent years. We found different seasonal incidence peaks among different age groups.
The effect of intermittent preventive treatment for malaria with dihydroartemisinin–piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial
Authors: Ludoviko Zirimenya, Agnes Natukunda, Jacent Nassuuna, Gyaviira Nkurunungi, Christopher Zziwa, Caroline Ninsiima, Christine Kukundakwe, Christine M Nankabirwa, Charity Katushabe, Loyce K Namusobya, Gloria Oduru, Grace Kabami, Joel Kabali, John Kayiwa, Joyce Kabagenyi, Govert J van Dam, Paul L A M Corstjens, Stephen Cose, Anne Wajja, Sarah G Staedke, Pontiano Kaleebu, Alison M Elliott, Emily L Webb
Journal: The Lancet Global Health (2024)
Paternal metformin use and risk of congenital malformations in offspring in Norway and Taiwan: population based, cross national cohort study
Authors: Lin-Chieh Meng, Marleen M H J van Gelder, Hui-Min Chuang, Liang-Kung Chen, Fei-Yuan Hsiao, Hedvig M E Nordeng
Journal: BMJ (2024)

Abstract Objective To evaluate the association between paternal metformin use and risk of congenital malformations in offspring. Design Population based, cross national cohort study. Setting Norway and Taiwan. Participants 619 389 offspring with paternal data during the period of sperm development (three months before pregnancy) in the Norwegian cohort during 2010-21 and 2 563 812 in the Taiwanese cohort during 2004-18. Main outcome measures The primary outcome was any congenital malformation, and the secondary outcome was organ specific malformations, classified according to the European surveillance of congenital anomalies guidelines. Relative risks were estimated with an unadjusted analysis and with analyses restricted to the cohort of men with type 2 diabetes mellitus and those using overlap propensity score weighting to control for severity of diabetes and other potential confounders. Sibling matched comparisons were conducted to account for genetic and lifestyle factors. Relative risk estimates for Norwegian and Taiwanese data were pooled using a random effects meta-analytical approach. Results Paternal data on metformin use during the period of sperm development was available for 2075 (0.3%) offspring in Norway and 15 276 (0.6%) offspring in Taiwan. Among these offspring, 104 (5.0%) in Norway and 512 (3.4%) in Taiwan had congenital malformations. Increased risks of any congenital malformation associated with paternal metformin use were observed in the unadjusted analysis and attenuated with increasing control of confounding. The relative risks of any malformations with paternal metformin use were 1.29 (95% confidence interval 1.07 to 1.55) in Norway and 1.08 (0.99 to 1.17) in Taiwan in the unadjusted analysis and 1.20 (0.94 to 1.53) and 0.93 (0.80 to 1.07), respectively, in the analysis restricted to fathers with type 2 diabetes mellitus. In the overlap propensity score weighting analysis restricted to fathers with type 2 diabetes mellitus, the relative risks were 0.98 (0.72 to 1.33) in Norway and 0.87 (0.74 to 1.02) in Taiwan, resulting in a pooled estimate of 0.89 (0.77 to 1.03). No associations were observed between paternal metformin use and any organ specific malformations. These findings were consistent in sibling matched comparisons and sensitivity analyses. Conclusions The findings suggest that paternal use of metformin during the period of sperm development is not associated with congenital malformations in offspring, including organ specific malformations. Metformin can therefore continue to be considered a suitable initial oral agent for managing glucose levels in men with type 2 diabetes mellitus who plan on having children.
A loop-mediated isothermal amplification test for yaws: a multi-country diagnostic accuracy evaluation
Authors: Becca L Handley, Camila González-Beiras, Serges Tchatchouang, Kouadio Aboh Hugues, Laud Antony Basing, Aboubacar Sylla, Mireille S Kouamé-Sina, Ivy Amanor, Philippe Ndzomo, Axel Aloumba, Mohammed Bakheit, Claudia Müller, Nadine Borst, Emelie Landmann, Helena Gmoser, Tamara Härpfer, Lisa Becherer, Simone Lüert, Sieghard Frischmann, Sarah Burl, Earnest Njih Tabah, Tania Crucitti, Adingra Tano Kouadio, Daniel Kojo Arhinful, Patrick Awondo, Solange Ngazoa Kakou, Sara Eyangoh, Kennedy Kwasi Addo, Sascha Knauf, Oriol Mitjà, Emma Michèle Harding-Esch, Michael Marks
Journal: The Lancet Global Health (2024)
Combined Exposure to Folate and Lead during Pregnancy and Autistic-Like Behaviors among Canadian Children from the MIREC Pregnancy and Birth Cohort
Authors: Joshua D. Alampi, Bruce P. Lanphear, Amanda J. MacFarlane, Youssef Oulhote, Joseph M. Braun, Gina Muckle, Tye E. Arbuckle, Jillian Ashley-Martin, Janice M.Y. Hu, Aimin Chen, Lawrence C. McCandless
Journal: Environmental Health Perspectives (2024)

Folic acid (FA) supplementation may attenuate the associations between gestational exposure to certain chemicals and autism or autistic-like behaviors, but to our knowledge, this has not been assessed for lead. We examined whether the relationship between gestational blood-lead levels (BLLs) and autistic-like behaviors was modified by gestational plasma total folate concentrations, FA supplementation, and maternal methylenetetrahydrofolate reductase (MTHFR) 677C>T genotype. We used data from the Maternal-Infant Research on Environmental Chemicals study (2008-2011), a Canadian pregnancy and birth cohort study. Childhood autistic-like behaviors were documented in 601 children 3-4 y of age with the Social Responsiveness Scale-2 (SRS-2), where higher scores denote more autistic-like behaviors. We measured BLLs and plasma total folate concentrations during the first and third trimesters of pregnancy. We also estimated gestational FA supplementation via surveys and genotyped the maternal MTHFR 677C>T single nucleotide polymorphism (SNP). We estimated the confounder-adjusted associations between log2-transformed BLLs and SRS-2 scores by two indicators of folate exposure and maternal MTHFR 677C>T genotype using linear regression. Third-trimester BLLs were associated with increased SRS-2 scores [βadj=3.3; 95% confidence interval (CI): 1.1, 5.5] among participants with low (<10th percentile), third-trimester, plasma total folate concentrations, but BLL-SRS-2 associations were null (βadj=-0.3; 95% CI: -1.2, 0.5) among those in the middle category (≥10th and <80th percentiles) (p-interaction <0.001). FA supplementation also attenuated these associations. Both folate indicators modified first-trimester BLL-SRS-2 associations, but to a lesser extent. Third-trimester BLL-SRS-2 associations were slightly stronger among participants who were homozygous for the T (minor) allele of the MTHFR 677C>T SNP (βadj=0.9; 95% CI: -1.2, 3.1) than those without the T allele (βadj=-0.3; 95% CI: -1.3, 0.7), but the difference was not statistically significant (p-interaction=0.28). Folate may modify the associations between gestational lead exposure and childhood autistic-like behaviors, suggesting that it mitigates the neurotoxic effects of prenatal lead exposure. https://doi.org/10.1289/EHP14479.
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
Authors: Jacent Nassuuna, Ludoviko Zirimenya, Gyaviira Nkurunungi, Agnes Natukunda, Christopher Zziwa, Caroline Ninsiima, Barbara Apule, Caroline Onen, Susan Amongi, Joel Serubanja, Pius Tumwesige, Denis Nsubuga, Rebecca Amongin, Govert J van Dam, Paul L A M Corstjens, John Kayiwa, Joyce Kabagenyi, Stephen Cose, Anne Wajja, Pontiano Kaleebu, Emily L Webb, Alison M Elliott
Journal: The Lancet Global Health (2024)
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study
Authors: Luis Masana, Alberto Zambon, Claus Peter Schmitt, Christina Taylan, Joenna Driemeyer, Hofit Cohen, Paola Sabrina Buonuomo, Abdullah Alashwal, Mohammed Al-Dubayee, Naji Kholaif, José Luis Diaz-Diaz, Faouzi Maatouk, Sergio Martinez-Hervas, Brian Mangal, Sandra Löwe, Tracy Cunningham
Journal: The Lancet Diabetes & Endocrinology (2024)
Circulation of avian Chlamydia abortus in the Netherlands and community-acquired pneumonia: an outbreak investigation and retrospective cohort study
Authors: Stijn Raven, Marloes Heijne, Jeroen Koomen, Gert Doornenbal, Miriam Maas, Pieter Jacobs, Ingrid Keur, Frederika Dijkstra, Daphne Reukers, Mark Platenburg, Stephan P Verweij, Hans-Jurgen Mager, Joan Totté, Saara Vainio, Maarten Bongaerts, Edou Heddema
Journal: The Lancet Infectious Diseases (2024)
Access to diagnostic imaging and radiotherapy technologies for patients with cancer in the Baltic countries, eastern Europe, central Asia, and the Caucasus: a comprehensive analysis
Authors: Manjit Dosanjh, Vesna Gershan, Eugenia C Wendling, Jamal S Khader, Taofeeq A Ige, Mimoza Ristova, Richard Hugtenburg, Petya Georgieva, C Norman Coleman, David A Pistenmaa, Gohar H Hovhannisyan, Tatul Saghatelyan, Kamal Kazimov, Rovshan Rzayev, Gulam R Babayev, Mirzali M Aliyev, Eduard Gershkevitsh, Irina Khomeriki, Lily Petriashvili, Maia Topeshashvili, Raushan Zakirova, Aigerim Rakhimova, Natalya Karnakova, Aralbaev Rakhatbek, Narynbek Kazybaev, Oksana Bondareva, Kristaps Palskis, Gaļina Boka, Erika Korobeinikova, Linas Kudrevicius, Ion Apostol, Ludmila V Eftodiev, Alfreda Rosca, Galina Rusnac, Mukhabatsho Khikmatov, Sergii Luchkovskyi, Yuliia Severyn, Jamshid M Alimov, Munojat Ismailova, Suvsana M Talibova
Journal: The Lancet Oncology (2024)
Genetic sequencing analysis of monkeypox virus clade I in Republic of the Congo: a cross-sectional, descriptive study
Authors: Claude Kwe Yinda, Félix Koukouikila-Koussounda, Pembe Issamou Mayengue, Reiche Golmard Elenga, Benjamin Greene, Missiani Ochwoto, Ghislain Dzeret Indolo, Yanne Vanessa Thiécesse Mavoungou, Dachel Aymard Eyenet Boussam, Bani Reize Vishnou Ampiri, Chastel Claujens Mapanguy Mfoutou, Yvanhe Deho Kianguebeni Mbouala, Francine Ntoumi, Jean-Médard Kankou, Vincent J Munster, Fabien Roch Niama
Journal: The Lancet (2024)
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
Authors: Gyaviira Nkurunungi, Jacent Nassuuna, Agnes Natukunda, Ludoviko Zirimenya, Bridgious Walusimbi, Christopher Zziwa, Caroline Ninsiima, Joyce Kabagenyi, Prossy N Kabuubi, Govert J van Dam, Paul L A M Corstjens, John Kayiwa, Moses Kizza, Alex Mutebe, Esther Nakazibwe, Florence A Akello, Moses Sewankambo, Samuel Kiwanuka, Stephen Cose, Anne Wajja, Pontiano Kaleebu, Emily L Webb, Alison M Elliott
Journal: The Lancet Global Health (2024)
Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan
Authors: Robin C Nesbitt, Andrew S Azman, Vincent Kinya Asilaza, Jessie K Edwards, Priscillah Gitahi, Patrick Nkemenang, Jetske Duncker, Melat Haile, Primitive Gakima, Joseph F Wamala, Fredrick Beden Loro, Duol Biem, Nelly Staderini, Manuel Albela, Monica Rull, John Rumunu, Iza Ciglenecki, Etienne Gignoux
Journal: The Lancet Global Health (2024)